Showing 1,945 to 1,956 of 2,180 results
Supreme Court to Hear Case on Gender-Transition Care for Minors
The Supreme Court will decide if Tennessee's ban on gender-transition treatments for transgender minors violates the Equal Protection Clause, impacting healthcare access for this population and setting a national precedent.
Supreme Court to Hear Case on Gender-Transition Care for Minors
The Supreme Court will decide if Tennessee's ban on gender-transition treatments for transgender minors violates the Equal Protection Clause, impacting healthcare access for this population and setting a national precedent.
Progress
36% Bias Score
Supreme Court Weighs Tennessee's Ban on Gender-Affirming Care for Minors
The Supreme Court heard arguments on Tennessee's ban on gender-affirming care for minors, with conservative justices expressing skepticism while liberal justices emphasized the potential harms of such bans; a decision is expected by June.
Supreme Court Weighs Tennessee's Ban on Gender-Affirming Care for Minors
The Supreme Court heard arguments on Tennessee's ban on gender-affirming care for minors, with conservative justices expressing skepticism while liberal justices emphasized the potential harms of such bans; a decision is expected by June.
Progress
40% Bias Score
US Healthcare in 2025: Navigating Cybersecurity, CX, and Regulatory Changes
The US healthcare industry enters 2025 facing the consequences of 2024's cybersecurity breaches, poor customer experiences, and strained payer-provider relations, leading to increased cybersecurity regulations, AI adoption for improved CX, and a shift towards more human-centered healthcare interacti...
US Healthcare in 2025: Navigating Cybersecurity, CX, and Regulatory Changes
The US healthcare industry enters 2025 facing the consequences of 2024's cybersecurity breaches, poor customer experiences, and strained payer-provider relations, leading to increased cybersecurity regulations, AI adoption for improved CX, and a shift towards more human-centered healthcare interacti...
Progress
40% Bias Score
Muface Healthcare Renewal Faces Crisis as Insurers Demand Higher Premiums
The Muface healthcare agreement for 1.53 million Spanish public employees and their families is expiring on December 31st, and the renewal process has hit a snag due to insurers demanding significantly higher premiums than the government's initial offer.
Muface Healthcare Renewal Faces Crisis as Insurers Demand Higher Premiums
The Muface healthcare agreement for 1.53 million Spanish public employees and their families is expiring on December 31st, and the renewal process has hit a snag due to insurers demanding significantly higher premiums than the government's initial offer.
Progress
48% Bias Score
Mexican Congress Approves Vape Ban, Budget, and Other Constitutional Reforms
The Mexican Congress swiftly approved constitutional amendments banning vapes, fentanyl, and other substances, expanding offenses with mandatory preventive detention, eliminating seven autonomous bodies, and preparing for the 2025 budget's discussion, totaling 9.3 billion pesos.
Mexican Congress Approves Vape Ban, Budget, and Other Constitutional Reforms
The Mexican Congress swiftly approved constitutional amendments banning vapes, fentanyl, and other substances, expanding offenses with mandatory preventive detention, eliminating seven autonomous bodies, and preparing for the 2025 budget's discussion, totaling 9.3 billion pesos.
Progress
48% Bias Score
Pfizer Stock Plunges 50% Amidst Falling Sales and Vaccine Concerns
Pfizer stock is down 50% since early 2022 to $26, driven by a 42% fall in 2023 sales to $58.5 billion following the Covid-19 pandemic and concerns over new leadership's stance on vaccines, despite efforts to cut costs and develop new drugs.
Pfizer Stock Plunges 50% Amidst Falling Sales and Vaccine Concerns
Pfizer stock is down 50% since early 2022 to $26, driven by a 42% fall in 2023 sales to $58.5 billion following the Covid-19 pandemic and concerns over new leadership's stance on vaccines, despite efforts to cut costs and develop new drugs.
Progress
40% Bias Score
Supreme Court Hears Case Challenging Ban on Gender-Affirming Care for Minors
The Supreme Court heard arguments in *United States v. Skrmetti*, a case challenging a Tennessee law banning gender-affirming care for minors; a decision is expected by late June, with the conservative majority seemingly favoring Tennessee, potentially impacting transgender rights nationwide.
Supreme Court Hears Case Challenging Ban on Gender-Affirming Care for Minors
The Supreme Court heard arguments in *United States v. Skrmetti*, a case challenging a Tennessee law banning gender-affirming care for minors; a decision is expected by late June, with the conservative majority seemingly favoring Tennessee, potentially impacting transgender rights nationwide.
Progress
44% Bias Score
Letby Interviewed in Prison Amidst Ongoing Baby Deaths Investigation
Lucy Letby, serving a whole-life sentence for murdering seven babies and attempting to murder seven others, was interviewed in prison regarding an ongoing investigation into additional baby deaths and non-fatal collapses at the Countess of Chester Hospital and Liverpool Women's Hospital, where she p...
Letby Interviewed in Prison Amidst Ongoing Baby Deaths Investigation
Lucy Letby, serving a whole-life sentence for murdering seven babies and attempting to murder seven others, was interviewed in prison regarding an ongoing investigation into additional baby deaths and non-fatal collapses at the Countess of Chester Hospital and Liverpool Women's Hospital, where she p...
Progress
40% Bias Score
3 Million Face Medicaid Loss Under Potential Republican Cuts
Nine states with trigger laws risk losing Medicaid coverage for over 3 million people if Republicans cut federal funding for the Affordable Care Act's Medicaid expansion, potentially impacting access to care for millions of low-income Americans.
3 Million Face Medicaid Loss Under Potential Republican Cuts
Nine states with trigger laws risk losing Medicaid coverage for over 3 million people if Republicans cut federal funding for the Affordable Care Act's Medicaid expansion, potentially impacting access to care for millions of low-income Americans.
Progress
40% Bias Score
Mistaking Covid for a cold puts vulnerable people at risk
In the week ending November 15th, 122 Covid-related deaths occurred in England and Wales, while a lack of testing due to people mistaking Covid for a cold is putting vulnerable people at risk, especially those unaware of antiviral treatments.
Mistaking Covid for a cold puts vulnerable people at risk
In the week ending November 15th, 122 Covid-related deaths occurred in England and Wales, while a lack of testing due to people mistaking Covid for a cold is putting vulnerable people at risk, especially those unaware of antiviral treatments.
Progress
32% Bias Score
Astellas to Launch Innovative Cancer Treatments in China Amidst Growing Market
Astellas, a multinational pharmaceutical company, is bringing two innovative cancer treatments to China, capitalizing on the country's massive consumer base, strengthened IP protection, and improved innovation climate; China's elderly population exceeded 20% in 2022.
Astellas to Launch Innovative Cancer Treatments in China Amidst Growing Market
Astellas, a multinational pharmaceutical company, is bringing two innovative cancer treatments to China, capitalizing on the country's massive consumer base, strengthened IP protection, and improved innovation climate; China's elderly population exceeded 20% in 2022.
Progress
36% Bias Score
Egypt Partially Pays $120M in Pharmaceutical Arrears, Addressing Drug Shortages
The Egyptian government disbursed 4 billion Egyptian pounds ($80.2 million) to pharmaceutical companies, addressing 6 billion pounds ($120.5 million) in arrears, alleviating drug shortages caused by currency devaluation and import cost increases; additional payments totaling 6 billion pounds ($120.3...
Egypt Partially Pays $120M in Pharmaceutical Arrears, Addressing Drug Shortages
The Egyptian government disbursed 4 billion Egyptian pounds ($80.2 million) to pharmaceutical companies, addressing 6 billion pounds ($120.5 million) in arrears, alleviating drug shortages caused by currency devaluation and import cost increases; additional payments totaling 6 billion pounds ($120.3...
Progress
32% Bias Score
Showing 1,945 to 1,956 of 2,180 results